infectious diseases

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Missing the primary endpoint in a phase 3 trial will not stop Pfizer from submitting Valneva-partnered Lyme disease vaccine for approval.

News

Hope rises for vaccine against hookworm parasite

Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.

News

Meningitis outbreak in UK prompts call to widen vaccination

A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.

News

China clears its first drug for chronic hepatitis D

Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.

News

Vaccination fall costs UK its measles elimination status

The UK has lost its measles elimination status, according to the WHO, due to a spike in cases in 2024 and a fall in vaccination coverage.

EU invests €30m to fight antimicrobial resistance

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Hope rises for vaccine against hookworm parasite

Meningitis outbreak in UK prompts call to widen vaccination

China clears its first drug for chronic hepatitis D

Vaccination fall costs UK its measles elimination status

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

infectious diseases

Editor's Picks